Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Feras Almourfi"'
Autor:
Saranya Rameshbabu, Zeyad Alehaideb, Sahar S. Alghamdi, Rasha S. Suliman, Feras Almourfi, Syed Ali Mohamed Yacoob, Anuradha Venkataraman, Safia Messaoudi, Sabine Matou-Nasri
Publikováno v:
Metabolites, Vol 14, Iss 7, p 368 (2024)
There is a growing interest in the discovery of novel xanthine oxidase inhibitors for gout prevention and treatment with fewer side effects. This study aimed to identify the xanthine oxidase (XO) inhibitory potential and drug-likeness of the metaboli
Externí odkaz:
https://doaj.org/article/ff8fd784df8a468c86cbfaa3fc51920d
Autor:
Khalid Alghamdi, Zeyad Alehaideb, Ashok Kumar, Hamad Al-Eidi, Sahar S. Alghamdi, Rasha Suliman, Rizwan Ali, Feras Almourfi, Saleh M. Alghamdi, Mohamed Boudjelal, Sabine Matou-Nasri
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
There is no first-line treatment for vitiligo, a skin disease characterized by a lack of melanin produced by the melanocytes, resulting in an urgent demand for new therapeutic drugs capable of stimulating melanocyte functions, including melanogenesis
Externí odkaz:
https://doaj.org/article/8f8bc0b2174e4db5a9f538dfba18f04e
Autor:
Bandar Alghanem, Fatmah A. Mansour, Hayat Shaibah, Khawlah Almuhalhil, Feras Almourfi, Hassan S. Alamri, Hala Alajmi, Mamoon Rashid, Fayhan Alroqi, Maroua Jalouli, Abdel Halim Harrath, Mohammad Boudjellal, Tlili Barhoumi
Publikováno v:
Heliyon, Vol 9, Iss 4, Pp e15224- (2023)
Treatment of severe cases of coronavirus disease 2019 (COVID-19) is extremely important to minimize death and end-organ damage. Here we performed a proteomic analysis of plasma samples from mild, moderate and severe COVID-19 patients. Analysis reveal
Externí odkaz:
https://doaj.org/article/3af63835a8d34161bc9ce014382e7971
Autor:
Majed Dasouki, Ayodeele Alaiya, Tanziel ElAmin, Zakia Shinwari, Dorota Monies, Mohamed Abouelhoda, Amjad Jabaan, Feras Almourfi, Zuhair Rahbeeni, Fahad Alsohaibani, Fahad Almohareb, Hazzaa Al-Zahrani, Francisco J. Guzmán Vega, Stefan T. Arold, Mahmoud Aljurf, Syed Osman Ahmed
Publikováno v:
iScience, Vol 24, Iss 3, Pp 102214- (2021)
Summary: Autosomal recessive mutations in G6PC3 cause isolated and syndromic congenital neutropenia which includes congenital heart disease and atypical inflammatory bowel disease (IBD). In a highly consanguineous pedigree with novel mutations in G6P
Externí odkaz:
https://doaj.org/article/e70cc78710c248be86f58e5e90251a2b
Autor:
Kalyanasundaram Subramanian, Karolina Mitusińska, John Raedts, Feras Almourfi, Henk-Jan Joosten, Sjon Hendriks, Svetlana E. Sedelnikova, Servé W. M. Kengen, Wilfred R. Hagen, Artur Góra, Vitor A. P. Martins dos Santos, Patrick J. Baker, John van der Oost, Peter J. Schaap
Publikováno v:
Biomolecules, Vol 9, Iss 6, p 212 (2019)
The cupin-type phosphoglucose isomerase (PfPGI) from the hyperthermophilic archaeon Pyrococcus furiosus catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate. We investigated PfPGI using protein-engineering bioinformat
Externí odkaz:
https://doaj.org/article/3ade833aae9f4dc9bba8abd111a6ffad
Autor:
Zakia Shinwari, Francisco J. Guzmán Vega, Feras Almourfi, Fahad Alsohaibani, Tanziel ElAmin, Fahad Almohareb, Zuhair Rahbeeni, Amjad Jabaan, Dorota Monies, Mahmoud Aljurf, Syed Osman Ahmed, Stefan T. Arold, Majed Dasouki, Mohamed Abouelhoda, Ayodeele Alaiya, Hazzaa Alzahrani
Publikováno v:
iScience, Vol 24, Iss 3, Pp 102214-(2021)
iScience
iScience
Summary Autosomal recessive mutations in G6PC3 cause isolated and syndromic congenital neutropenia which includes congenital heart disease and atypical inflammatory bowel disease (IBD). In a highly consanguineous pedigree with novel mutations in G6PC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64232a4d81629a6588a84ccbd26be574
https://doi.org/10.1016/j.isci.2021.102214
https://doi.org/10.1016/j.isci.2021.102214